E85.9

Amyloidosis, unspecified

Billable / specificHCC V28 50

E85.9 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.

Inclusion terms

Includes (from E85)

  • Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Excludes1

Not coded here — never report together with this code.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74) (from E85)
  • androgen insensitivity syndrome (E34.5-) (from E85)
  • congenital adrenal hyperplasia (E25.0) (from E85)
  • hemolytic anemias attributable to enzyme disorders (D55.-) (from E85)
  • Marfan syndrome (Q87.4-) (from E85)
  • 5-alpha-reductase deficiency (E29.1) (from E85)

Excludes2

Not included here — may be reported together when both conditions exist.

  • Ehlers-Danlos syndromes (Q79.6-) (from E85)
  • Alzheimer's disease (G30.0-) (from E85)

Also known as

  • Amyloidosis
  • Degeneration, degenerative, amyloid

Parent code

  • E85AmyloidosisHeader

Related codes

  • E85.0Non-neuropathic heredofamilial amyloidosisBillable
  • E85.1Neuropathic heredofamilial amyloidosisBillable
  • E85.2Heredofamilial amyloidosis, unspecifiedBillable
  • E85.3Secondary systemic amyloidosisBillable
  • E85.4Organ-limited amyloidosisBillable
  • E85.8Other amyloidosisHeader

Browse